Medical Extracorporeal Membrane Oxygenation Machine ECMO Market Analysis 2026

The Driving factors for the Medical Extracorporeal Membrane Oxygenation Machine ECMO market

• Rising Burden of Cardiovascular and Respiratory Diseases will propel the Market Growth

Increased prevalence of cardiovascular disease is causing a rise in their use. The common cardiovascular diseases like coronary heart disease, cerebrovascular disease, rheumatic and congenital heart diseases have a huge disease burden in the health system. Cardiovascular disorders are the most common cause of death globally.
In 2021, cardiovascular disease (CVD) resulted in an estimated 20.5 million deaths globally, as per the World Heart Federation.
https://world-heart-federation.org/world-heart-day/cvd-causes-conditions/what-is-cvd/ 
In addition, the increasing occurrence of respiratory diseases like Acute Respiratory Distress Syndrome (ARDS), chronic obstructive pulmonary diseases, COVID-19, and respiratory failure is another leading reason behind the high demand for such machines.
As an example, according to an article made public by the European Respiratory Society, over 4,600 lung transplant operations are done globally. The region of North America and Europe sees about 80% of all operations.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9489139/#:~:text=Annually%2C%20over%204%20600%20lung,cohorts%20%5B8%2C%209%5D.
Also, according to data released by ARDS, approximately 190,000 Americans are diagnosed with ARDS each year in the United States. Such widespread rise of cardiovascular and respiratory conditions has enhanced the application for these machines and is driving the growth of the extracorporeal membrane oxygenation machine market.

• Increase in lung transplantation procedures

There is a drastic increase in the number of lung transplants due to prevailing diseases like cystic fibrosis, chronic obstructive pulmonary disease (COPD), and interstitial lung disease. For many years, the adoption of ECMO machines in the lung transplantation process has significantly increased due to an increase in the number of severe lung diseases. In the post-lung transplantation hours, there is a rise in a lung injury called Primary Graft Dysfunction (PGD). This rise in PGD is the most common indication for the use of ECMO machines. The rising technologies in the ECO machines have shown positive outcomes in the therapy for patients suffering from PGD. Therefore, the increasing number of lung diseases and their transplants increase the use of ECMO machines, thereby driving their market growth. 

Restraining factor for Medical Extracorporeal Membrane Oxygenation Machine ECMO market

• High cost associated with the ECMO products

The Extracorporeal Membrane Oxygenation Machine therapy is quite expensive. The total costs of the ECMO therapy include the cost of a stay at the hospital and the cost of additional disposable accessories. ECMO therapy requires highly skilled professionals for the patient’s care and treatment of lung diseases. These standards for maintaining the quality of patient care and their treatment by skilled physicians add to the cost, which differs depending on the amount of time the machine is used. Additionally, the increasing technologies in the ECMO machines can lead to an increase in its cost. Thus, they are not affordable in developing countries, which may indirectly impede the market growth of EMCO machines.

Impact of the COVID-19 pandemic on the Extracorporeal Membrane Oxygenation Machine (ECMO) Market

the COVID-19 pandemic had a positive impact on the extracorporeal membrane oxygenation machine (ECMO) market. ECMO machine was used to treat COVID-19-associated acute respiratory distress syndrome (ARDS) patients. As reported by Extracorporeal Life Support Organization (ELSO), nearly 3,000 procedures took place during the pandemic with confirmed COVID-19 ARDS. Additionally, the developments in ECMO machine technology, like centrifugal pumps, dual lumen cannulas, and improved oxygenators, as well as widely improved staff training, drove its market growth due to the pandemic. Globally, during the spread of COVID-19, ECMO machines were widely recognized as a way to increase the survival of patients suffering from cardiac and respiratory diseases. Therefore, an increased number of patients with COVID-19-associated ARDS boosted the growth of the ECMO machine market globally.

Opportunity for Medical Extracorporeal Membrane Oxygenation Machine ECMO

Rising Technological Advancements Leading to Increased Product Adoption to Contribute to Market Growth

Miniaturization of the machine's components, for example, the oxygenator and hollow pumps, utilized in numerous surgeries, facilitates transportation of critical patients. Further, the addition of technologically sophisticated components, like enhanced rotary pumps, dual lumen cannula, novel oxygenators, and novel cannulation strategies, is expected to simplify the application of extracorporeal membrane oxygenation (ECMO) machines. The benefits provided by new devices over older equipment are quick priming time, reduced priming volume, low resistance to blood flow, and reduced plasma leakage, which can decrease platelet consumption and activation. Also, in sophisticated circuits, surface coatings that simulate the endothelial lining of blood vessels, decrease thrombogenicity, eliminate the need for continuous anticoagulation, and decrease the occurrence of associated complications.
For instance, in July 2022, Inspira Technologies OXY B.H.N. Ltd. launched the "Liby" System, a cutting-edge life support system employed to treat patients suffering from life-threatening heart and lung failure. Such breakthroughs and launch of new products will continue to spur market growth in the years ahead.
https://www.massdevice.com/inspira-liby-ecmo-heart-lung-failure/#:~:text=%E2%80%9CThe%20Liby%20system%20is%20expected%20to%20introduce,or%20via%20ambulance%2C%20and%20ease%20of%20use.
 

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Medical Extracorporeal Membrane Oxygenation Machine ECMO Market is witnessing significant growth in the near future.

In 2023, the Veno-Venous segment accounted for noticeable share of global Medical Extracorporeal Membrane Oxygenation Machine ECMO Market and is projected to experience significant growth in the near future.

The Cardiac application segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies Livanova Plc , LivaNova (Alung Technologies Inc.) and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Frequently Asked Questions (FAQs)